Skip to main content
Erschienen in: BMC Infectious Diseases 1/2009

Open Access 01.12.2009 | Correspondence

Mapping the history and current situation of research on John Cunningham virus – a bibliometric analysis

verfasst von: Hua-chuan Zheng, Lei Yan, Lei Cui, Yi-fu Guan, Yasuo Takano

Erschienen in: BMC Infectious Diseases | Ausgabe 1/2009

Abstract

Background

John Cunningham virus (JCV) constitutes a family of polyoma viruses, which plays important roles in the progressive multifocal leukoencephalopathy (PML) and tumorigenesis. However, no bibliometric investigation has been reported to guide the researchers and potential readers.

Methods

Papers were collected from database Sci-expanded and Pubmed until May 22, 2008. The highly-productive authors, institutes and countries, highly-cited authors and journals were ranked. The highly-cited articles were subjected to co-citation and chronological analysis with highly-frequent MeSH words for co-occurrence analysis.

Results

Until now, 1785 articles about JCV were indexed in Sci-expanded and 1506 in Pubmed. The main document type was original article. USA, Japan and Italy were the largest three producers about JCV. Temple University published 128 papers and ranked the top, followed by University of Tokyo. Khalili K and Yogo Y became the core authors due to more than 20 documents produced. Journal of Neurovirology published more than 15 papers and ranked the top. Padgett BL and Berger JR were the first two highly-cited authors. Journal of Virology and Journal of Neurovirology respectively ranked to the first two highly-cited journals. These top highly-cited articles were divided into 5 aspects: (1) The correlation between JC virus and tumors; (2) Causal correlation of JCV with PML; (3) Polyoma virus infection and its related diseases in renal-allograft recipients; (4) Detection of JCV antibody, oncogene and its encoding protein; (5) Genetics and molecular biology of JCV. The MeSH/subheadings were classified into five groups: (1) JCV and virus infectious diseases; (2) JCV pathogenicity and pathological appearance of PML; (3) JCV isolation and detection; (4) Immunology of JCV and PML; (5) JCV genetics and tumors.

Conclusion

JCV investigation mainly focused on its isolation and detection, as well as its correlation with PML and tumors. Establishment of transgenic animal model using JCV T antigen would be a hopeful and useful project in the further study.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1471-2334-9-28) contains supplementary material, which is available to authorized users.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

HCZ conceived the study and wrote the first and final draft of the manuscript, analyzed interpretation. LY extracted the data and performed the analyses. LC kindly provided the bibliometric software and kindly guidance. YFG and YT gave many good suggestions about data processing and manuscript. All authors read and approved the final manuscript.

Background

John Cunningham virus (JCV) constitutes a family of polyoma viruses, which contain small, circular and double-stranded DNA genomes. The early region is alternatively spliced to produce large T antigen and small t antigen [1]. T antigen, a large nuclear phosphoprotein for viral DNA replication, binds to viral replication region to promote the unwinding of double helix and recruitment of cell proteins that are required for DNA synthesis. The late region encodes the capsid structural protein VP1, VP2 and VP3 due to alternative splicing and the small regulatory protein known as agnoprotein [1, 2]. VP proteins are essential to assemble with viral DNA to form virons. Serological studies have indicated an asymptomatic JCV infection in about 90% of the adult population, but it may be activated under immunosuppressive conditions, leading to the lethal demyelinating disease, progressive multifocal leukoencephalopathy (PML) [15]. Evidences from transgenic and infectious animal models indicated that JCV could transform cells and cause various malignancies [69]. In recent years, links have been suggested between JCV and various types of human cancers, including colorectal, prostate and esophageal cancers, brain tumors, bronchopulmonary carcinoma and B cell lymphoma [19], pointing out its roles as oncovirus. However, no bibliometric investigation has been reported to guide the researchers and potential readers.
Investigators in some fields commonly predict that decision making for the following experiments, clinical practice and paper's submission should be based on the findings of scientific studies published in journals. Although scientific papers have provided useful and helpful information to the readers, it is a little difficult to learn about the history, status and future trend of some study field. The bibliometric method employs empiric data and quantitative analysis to trace the core production or citation, the content or quality of publications, and motivations of the researchers in the form of published literature so that it proves to be a valid and reliable way to map external and internal features of a scientific field [10]. A key assumption underpinning this method to catch insight into the flow of knowledge is that investigation papers represent knowledge produced by scientific research. Generally, academic productivity of individuals or groups is measured by counting the number of publications. The number of times that one work is cited is viewed as a measure of research impact. That is, the more frequently a paper is cited, the higher its impact or quality [10, 11]. Examination of bibliometric information shows the communication patterns of the investigation within the field and the patterns of influence among different work. Authors who publish earlier and experience frequent citations tend to accrue the number of citations over time as Matthew effect describes. For example, co-citation analysis (in which two papers are cited together in a paper) can indicate a strong conceptual relationship between the studies. On the other hand, PubMed indexes journal articles using MeSH terms, which constitute a thesaurus that embodies all the concepts appearing in the medical literature and are arranged in a hierarchical, tree-like structure by subject categories. Associated with MeSH is a list of corresponding subheadings to enhance the focus of MeSH searches. The combination of MeSH terms and subheadings can not only facilitate the sensitivity and specificity of search, but also indicate the research contents and the relationship between papers [1214]. If the further co-occurrence cluster analysis of MeSH is applied in some field, the close link between subtrees of the field will be well established.
In the present study, production and citation of JCV research have been analyzed using such bibliometric methods as chronological, co-citation and co-occurrence analysis to explore the whole history, current status and frontier about JCV study.

Methods

Data collection

The bibliographic data were collected in the database of the Institute for Scientific Information available on the web (http://​www.​isiknowledge.​com, Sci-expanded) and National Library of Medicine on the web (http://​www.​ncbi.​nlm.​nih.​gov/​sites/​entrez, Pubmed) until May 22, 2008. The tile, author, address, source, references or the US list of the papers were downloaded according to the retrieval strategy of "JC virus OR John Cunningham virus OR JCV OR JC polyomavirus OR JC polyoma virus" for Sci-expanded or Pubmed.

Highly-produced and -cited analysis

Using Foxpro 5.0, Microsoft Excel, Bibliographic Item Co-occurrence Mining System (BIOCOMS) provided by Cui Lei and Sci-expanded statistical system, we applied Sci-expanded data to determine the document types, core authors, highly-produced institutes and countries. The references were analyzed to clarify the distribution of highly-cited papers, authors and journals. The top MeSH/subheading words were collected from Pubmed and subjected to statistical analysis for highly-frequent ones.

Cluster analysis

After their identification, the top 34 most-cited articles were subjected to co-citation cluster analysis according to their co-citation times in one paper. The 48 highly-frequent MeSH/subheadings of all articles from Pubmed were studied using co-occurrence cluster analysis in term of their co-existence times in one paper. In any cluster analysis, the matrixes were built up according to co-citation or -occurrence times between the selected articles or words. Then, the related matrixes were developed using Ochiai index as previously described [1518]. Finally, we employed the SPSS 10.0 software to perform the cluster analysis of these related matrixes.

Results

Core countries, institutes, authors and journals

Until May 22, 2008, 1785 articles about JCV were indexed in Sci-expanded with 62508 references and 1506(225 reviews) in Pubmed with 6435 major MeSH/subheading words. The literature about JCV was gradually rising from 3 articles in 1976 until 179 in 2006 as indicated in Figure 1. The average annual growth rate was 5.7 pieces in the period. According to document type, there were 1307 original articles (73.2%), 123 reviews (6.9%) and 209 meeting abstracts (11.7%) in all collected literature (Table 1). In overall 21 countries listed, USA, Japan, Italy and Germany were in order the largest four producers about JCV despite 62 countries included (Table 2). The overall 1245 institutes were mentioned to investigate JCV, among which Temple University of USA published 128 papers and ranked the top, followed by University of Tokyo, and National Institute of Neurological Disorder and Stroke subsequently. Fourteen of 21 (66.7%) core institutes come from USA with three core institutes in Italy (Table 3). Such 33 authors as Khalili K, Yogo Y and etc produced more than 20 documents in spite of all 4856 authors involved. There were 9 highly-produced scientists from Temple University and 6 from University of Tokyo, Japan, and 4 from National Institute of Neurological Disorder and Stroke, USA respectively (Table 4). As shown in Table 5, Journal of Neurovirology, Journal of Virology, Virology, Journal of Medical Virology, Journal of General Virology and so forth published more than 15 papers and were considered as the core journals although there existed JCV papers in 395 journals. These source journals mainly include the field of Virology, Neurosciences, Clinical Neurology, Immunology, Pathology, Oncology and so on (Table 6).
Table 1
Document types of the scientific papers about JCV
Num
Document type
Record count
Percentage(%)
1
Original article
1307
73.2
2
Meeting abstract
209
11.7
3
Review
123
6.9
4
Note
63
3.5
5
Letter
40
2.2
6
Editorial material
31
1.7
7
Correction
4
0.20
8
Book review
3
0.17
9
Discussion
2
0.11
Table 2
The territory distribution of the scientific papers about JCV
Num
Country
Record count
Percentage(%)
1
USA
968
54.2
2
Japan
190
10.6
3
Italy
173
9.7
4
Germany
158
8.8
5
UK
88
5.0
6
France
72
4.0
7
Spain
48
2.7
8
Switzerland
44
2.5
9
Canada
37
2.1
10
Sweden
36
2.0
11
Taiwan
24
1.3
12
Norway
22
1.2
13
China
15
0.8
14
Australia
14
0.8
15
Poland
13
0.7
16
Belgium
12
0.7
17
Brazil
12
0.7
18
South Korea
12
0.7
19
Lithuania
11
0.6
20
Finland
10
0.6
21
Netherlands
10
0.6
Table 3
The core institutes to investigate the JCV
Num
Institution name
Country
Record count
Percentage(%)
1
Temple University
USA
128
7.2
2
University of Tokyo
Japan
86
4.8
3
National Institute of Neurological and Communication Disorders and Stroke
USA
79
4.4
4
Harvard University
USA
61
3.4
5
Hokkaido University
Japan
59
3.3
6
National Institute of Neurological Disorder and Stroke
USA
56
3.1
7
Pennsylvania State University
USA
56
3.1
8
Thomas Jefferson University
USA
47
2.6
9
University of Milan
Italy
40
2.2
10
University of Wisconsin
USA
39
2.2
11
Brown University
USA
38
2.1
12
Johns Hopkins University
USA
36
2.0
13
National Cancer Institute
USA
32
1.8
14
University of California san Diego
USA
31
1.7
15
University of Wurzburg
Germany
29
1.6
16
University of Pittsburgh
USA
28
1.6
17
IRCCS
Italy
25
1.4
18
Baylor College of Medicine
USA
24
1.3
19
University of Hamburg
Germany
24
1.3
20
National Institute of Health
USA
23
1.3
21
University of Ferrara
Italy
20
1.1
Table 4
The core authors for JCV investigation
Num
Core author
Institutes
Record count
Percentage(%)
1
Khalili K
Temple University, USA
174
9.8
2
Yogo Y
University of Tokyo, Japan
75
4.2
3
Major EO
National Institute of Neurological Disorders and Stroke, USA
74
4.2
4
Stoner GL
National Institute of Neurological Disorders and Stroke, USA
70
3.9
5
Del Valle L
Temple University, USA
62
3.5
6
Kitamura T
University of Tokyo, Japan
59
3.3
7
Nagashima K
Hokkaido University, Japan
57
3.2
8
Frisque RJ
Pennsylvania State University, USA
48
2.7
9
Ryschkewitsch CF
National Institute of Neurological Disorders and Stroke, USA
45
2.5
10
Koralnik IJ
Harvard Medical School, USA
43
2.4
11
Gordon J
Temple University, USA
42
2.4
12
Sugimoto C
University of Tokyo, Japan
41
2.3
13
Atwood WJ
Brown University, USA
40
2.2
14
Walker DL
University of Wisconsin Medical School, USA
39
2.2
15
Zheng HY
University of Tokyo, Japan
37
2.1
16
Ferrante P
University of Milan, Italy
33
1.9
17
Sawa H
Hokkaido University, Japan
32
1.8
18
Agostini HT
National Institute of Neurological Disorders and Stroke, USA
28
1.6
19
Boland CR
Baylor University Medical Center, USA
27
1.5
20
Takasaka T
University of Tokyo, Japan
26
1.5
21
White MK
Temple University, USA
26
1.5
22
Croul S
Temple University, USA
25
1.4
23
Safak M
Temple University, USA
25
1.4
24
Wegner M
Universität Hamburg, Germany
25
1.4
25
Amini S
Temple University, USA
24
1.3
26
Padgett BL
University of Wisconsin Medical School, USA
23
1.3
27
Reiss K
Temple University, USA
22
1.2
28
Tanaka S
Hokkaido University, Japan
22
1.2
29
Berger JR
Temple University, USA
21
1.2
30
Butel JS
Baylor University Medical Center, USA
21
1.2
31
Dorries K
Universität Würzburg, Germany
21
1.2
32
Shah KV
Johns Hopkins Bloomberg School of Public Health, USA
21
1.2
33
Ikegaya H
University of Tokyo, Japan
20
1.1
Table 5
Core journals of JCV investigation
Num
Source title
Record count
Percentage(%)
1
Journal of Neurovirology
167
9.4
2
Journal of Virology
128
7.2
3
Virology
69
3.9
4
Journal of Medical Virology
51
2.9
5
Journal of General Virology
44
2.5
6
Annals of Neurology
36
2.0
7
Journal of Infectious Diseases
35
2.0
8
Journal of Clinical Micrology
31
1.7
9
Journal of Neuropathology and Experimental Neurology
31
1.7
10
AIDS
29
1.6
11
Journal of Biological Chemistry
29
1.6
12
Neurology
29
1.6
13
Oncogene
25
1.4
14
Proceedings of The National Academy of Sciences of The United States of America
25
1.4
15
Journal of Virological Methods
24
1.3
16
Transplantation
23
1.3
17
Gastroenterology
21
1.2
18
Anthropological Science
20
1.1
19
International Journal of Cancer
20
1.1
20
Polyomaviruses and Human Diseases
19
1.1
21
Archives of Virology
17
1.0
22
Clinical Infectious Diseases
16
0.9
23
American Journal of Transplantation
15
0.8
24
New England Journal of Medicine
15
0.8
Table 6
Subject categories for JCV investigation
Num
Subject category
Record count
Percentage (%)
1
Virology
601
33.7
2
Neurosciences
329
18.4
3
Clinical Neurology
238
13.3
4
Immunology
154
8.6
5
Pathology
154
8.6
6
Oncology
144
8.1
7
Biochemistry & Molecular Biology
142
8.0
8
Infectious Diseases
128
7.2
9
Biotechnology & Applied Microbiology
103
5.8
10
Cell Biology
85
4.8
11
Microbiology
80
4.5
12
Transplantation
80
4.5
13
Surgery
73
4.1
14
Genetics & Heredity
61
3.4
15
Medicine, Research & Experimental
60
3.4
16
Medicine, General & Internal
58
3.3
17
Evolutionary Biology
40
2.2
18
Hematology
35
2.0
19
Urology & Nephrology
34
1.9
20
Pediatrics
33
1.9
21
Biochemical Research Methods
32
1.8
22
Gastroenterology & Hepatology
31
1.7
23
Multidisciplinary Sciences
31
1.7

Highly-cited authors, journals and papers

The papers of 10 highly-cited authors (totally 1577 producers) like Padgett BL and Berger JR were cited for more than 400 times, among whom 8 persons come from USA (Table 7). The 10 highly-cited journals (totally 3584 journals) were selected due to more than 1179 citation times, including 3 for Virology and 4 for comprehensive journals (Table 8). Journal of Virology and Journal of Neurovirology respectively ranked to the first two among 404 cited journals (Table 9). The highly-cited papers were chronologically analyzed and grouped into two stages: (1) 1971–1984: discovery and isolation of JCV in PML disease and (2) 1985-present: clarification of JCV genomic DNA sequence and its correlation with diseases (Table 9).
Table 7
The highly-cited authors for JCV papers
Num
Authors
Institute
CT
CP(%)
1
Padgett BL
University of Wisconsin Medical School, USA
958
1.53
2
Berger JR
University of Kentucky, USA
761
2.75
3
Agostini HT
National Institute of Neurological Disorders and Stroke, USA
649
3.79
4
Frisque RJ
Pennsylvania State University, USA
630
4.80
5
Major EO
National Institute of Neurological Disorders and Stroke, USA
604
5.77
6
Walker DL
Tulane University, USA
495
6.56
7
Arthur RR
Johns Hopkins University, USA
430
7.25
8
Dorries K
University of Wurzburg, Germany
419
7.92
9
Yogo Y
University of Tokyo, Japan
415
8.58
10
Shah KV
Johns Hopkins University, USA
400
9.23
CT, cited time; CP, cumulative percentage
Table 8
The highly-cited journals for JCV papers
Num
Journal
CT
CP(%)
1
Journal of Virology
5871
9.43
2
Virology
2498
13.44
3
Proceedings of The National Academy of Sciences of The United States of America
2313
17.16
4
Journal of Infectious Diseases
2230
20.74
5
New England Journal of Medicine
1655
23.40
6
Journal of Neurovirology
1274
25.45
7
Science
1230
27.42
8
Cell
1227
29.39
9
Journal of Clinical Microbiology
1201
31.32
10
Annals of Neurology
1179
33.22
CT, cited time; CP, cumulative percentage
Table 9
The highly-cited articles for the JCV investigation
N
Authors
Year
Title
Source
V
P
CT
CP
1
Padgett BL
1971
Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy.
Lancet
1
1257
366
0.59
2
Frisque RJ
1984
Human polyomavirus JC virus genome.
J Virol
51
458
360
1.16
3
Major EO
1992
Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain
Clin Microbiol Rev
5
49
285
1.62
4
Padgett BL
1973
Prevalence of antibodies in human sera against JC virus, an isolate from a case of progressive multifocal leukoencephalopathy
J Infect Dis
127
467
219
1.97
5
Chesters PM
1983
Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues.
J Infect Dis
147
676
215
2.31
6
Berger JR
1987
Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. A review of the literature with a report of sixteen cases.
Ann Intern Med
107
78
197
2.63
7
Astrom KE
1958
Progressive multifocal leuko-encephalopathy; a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin's disease
Brain
81
93
179
2.91
8
Yogo Y
1990
Isolation of a possible archetypal JC virus DNA sequence from nonimmunocompromised individuals.
J Virol
64
3139
172
3.19
9
Gardner SD
1971
New human papovavirus (B.K.) isolated from urine after renal transplantation
Lancet
1
1253
165
3.45
10
Tornatore C
1992
Detection of JC virus DNA in peripheral lymphocytes from patients with and without progressive multifocal leukoencephalopathy
Ann Neurol
31
454
146
3.69
11
Kitamura T
1990
High incidence of urinary JC virus excretion in nonimmunosuppressed older patients.
J Infect Dis
161
1128
136
3.90
12
Houff SA
1988
Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy.
New Engl J Med
318
301
135
4.12
13
Berger JR
1995
Progressive multifocal leukoencephalopathy: the evolution of a disease once considered rare
J Neurovirol
1
5
134
4.33
14
Arthur RR
1989
Detection of BK virus and JC virus in urine and brain tissue by the polymerase chain reaction.
J Clin Microbiol
27
1174
132
4.55
15
Walker DL
1973
Human papovavirus (JC): induction of brain tumors in hamsters
Science
181
674
128
4.75
16
Loeber G
1988
DNA rearrangements in organ-specific variants of polyomavirus JC strain GS
J Virol
62
1730
126
4.95
17
White FA
1992
JC virus DNA is present in many human brain samples from patients without progressive multifocal leukoencephalopathy
J Virol
66
5726
117
5.14
18
Agostini HT
1996
Genotype profile of human polyomavirus JC excreted in urine of immunocompetent individuals.
J Clin Microbiol
34
159
114
5.32
19
Bergsagel DJ
1992
DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood
New Engl J Med
326
988
108
5.49
20
Brooks BR
1984
Progressive multifocal leukoencephalopathy
Neurol Clin
2
299
108
5.67
21
Markowitz RB
1993
Incidence of BK virus and JC virus viruria in human immunodeficiency virus-infected and -uninfected subjects.
J Infect Dis
167
13
108
5.84
22
Kenney S
1984
Prospective study of the human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients.
Science
226
1337
107
6.01
23
London WT
1978
Brain tumors in owl monkeys inoculated with a human polyomavirus (JC virus).
Science
201
1246
106
6.18
24
Coleman DV
1980
A prospective study of human polyomavirus infection in pregnancy
J Infect Dis
142
1
105
6.35
25
Dorries K
1994
Infection of human polyomaviruses JC and BK in peripheral blood leukocytes from immunocompetent individuals.
Virology
198
59
105
6.52
26
Gardner SD
1984
Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients
J Clin Pathol
37
578
104
6.68
27
Flaegstad T
1991
Amplification and sequencing of the control regions of BK and JC virus from human urine by polymerase chain reaction
Virology
180
553
102
6.85
28
Hogan TF
1980
Human polyomavirus infections with JC virus and BK virus in renal transplant patients
Ann Intern Med
92
373
101
7.01
29
Martin JD
1985
Differences in regulatory sequences of naturally occurring JC virus variants
J Virol
53
306
97
7.16
30
Monaco MCG
1996
JC virus infection of hematopoietic progenitor cells, primary B lymphocytes, and tonsillar stromal cells: implications for viral latency.
J Virol
70
7004
96
7.32
31
Richardson EP
1961
Progressive multifocal leukoencephalopathy
New Engl J Med
265
815
95
7.47
32
Randhawa PS
1999
Human polyoma virus-associated interstitial nephritis in the allograft kidney.
Transplantation
67
103
92
7.62
33
Frisque RJ
1992
The molecular biology of JC virus, causative agent of progressive multifocal leukoenchephalpathy
Mol Neurovirology
 
25
92
7.76
34
Padgett BL
1977
JC virus, a human polyomavirus associated with progressive multifocal leukoencephalopathy: additional biological characteristics and antigenic relationships
Infect Immun
15
656
90
7.91
V, volume; P, page; CT, cited times; CP, cumulative percentage

Co-citation analysis of highly-cited articles

In the overall references about JCV, most highly-cited articles were published before 1999 with more than 90 citation times and came from major journals, such as Journal of Infectious Disease, Journal of Virology, Science, New England Journal of Medicine and so forth. As shown in Figure 2, these top highly-cited articles were divided into 5 aspects by co-citation analysis: (1) The correlation between JC virus and tumors; (2) Causal correlation of JCV with PML: pathogenesis and molecular biology; (3) Polyoma virus infection and its related diseases in renal-allograft recipients; (4) Detection of JCV antibody, gene and encoding protein; (5) Genetics and molecular biology of JCV.

Co-occurrence analysis of highly-frequent MeSH/subheading words

The 48 highly-frequent MeSH/subheading words generally existed for more than 25 times in the papers about JCV (Table 10). Among them, 17 words (35.4%) belonged to the C02 subcategory of MeSH (Viral Disease) and 15 (31.3%) to B04 subcategory (Viruses). These MeSH/subheadings were classified into five groups: (1) JCV and virus infectious diseases; (2) JCV pathogenicity and pathological appearance of PML; (3) JCV isolation and detection; (4) Immunology of JCV and PML; (5) JCV genetics and tumors(Figure 3).
Table 10
The highly-frequent MeSH/subheading words
Num
MeSH/subheading words
Subcategory number
Times
CP
1
JC Virus/Genetics
B04.280.640.615.400
289
4.49
2
JC Virus/Isolation and Purification
B04.280.640.615.400
216
7.84
3
Leukoencephalopathy, Progressive Multifocal/Virology
C02.182.500.300.500
115
9.63
4
Leukoencephalopathy, Progressive Multifocal/Diagnosis
C02.182.500.300.500
86
10.96
5
JC Virus/Physiology
B04.280.640.615.400
84
12.27
6
JC Virus/Immunology
B04.280.640.615.400
73
13.40
7
Polyomavirus/Genetics
B04.280.640.615
69
14.47
8
Leukoencephalopathy, Progressive Multifocal/Pathology
C02.182.500.300.500
68
15.53
9
BK Virus/Isolation and Purification
B04.280.640.615.100
68
16.58
10
DNA, Viral/Analysis
D13.444.308.568
64
17.57
11
Leukoencephalopathy, Progressive Multifocal/Drug Therapy
C02.182.500.300.500
58
18.48
12
JC Virus/Pathogenicity
B04.280.640.615.400
56
19.34
13
Tumor Virus Infections/Virology
C02.928
54
20.18
14
Polyomavirus Infections/Virology
C02.256.721
51
20.98
15
Leukoencephalopathy, Progressive Multifocal/Etiology
C02.182.500.300.500
50
21.75
16
BK Virus/Genetics
B04.280.640.615.100
50
22.53
17
Leukoencephalopathy, Progressive Multifocal/Microbiology
C02.182.500.300.500
47
23.26
18
Leukoencephalopathy, Progressive Multifocal/Complications
C02.182.500.300.500
45
23.96
19
JC Virus
B04.280.640.615.400
45
24.65
20
Polyomavirus/Isolation and Purification
B04.280.640.615
42
25.31
21
Acquired Immunodeficiency Syndrome/Complications
C02.782.815.616.400.040
39
25.91
22
Polyomaviridae
B04.280.640
38
26.50
23
DNA, Viral/Genetics
D13.444.308.568
37
27.08
24
HIV Infections/Complications
C02.782.815.616.400
36
27.64
25
Gene Expression Regulation, Viral
G05.315.385
35
28.18
26
Polymerase Chain Reaction/Methods
E05.393.620.500
34
28.71
27
Polyomavirus/Immunology
B04.280.640.615
34
29.23
28
Leukoencephalopathy, Progressive Multifocal/Immunology
C02.182.500.300.500
34
29.76
29
Tumor Virus Infections/Diagnosis
C02.928
33
30.27
30
Tumor Virus Infections/Complications
C02.928
33
30.79
31
Brain/Virology
A08.186.211
33
31.30
32
Capsid Proteins
D12.776.964.970.600.550
33
31.81
33
Brain/Pathology
A08.186.211
31
32.29
34
Promoter Regions (Genetics)
G06.184.603.080.689.675
31
32.77
35
Genes, Viral
G14.330.605
30
33.24
36
JC Virus/Metabolism
B04.280.640.615.400
30
33.71
37
Virus Replication
G04.185.515.880.941
29
34.16
38
Polyomavirus Infections/Complications
C02.256.721
28
34.59
39
DNA, Viral/Cerebrospinal Fluid
D13.444.308.568
28
35.03
40
Neuroglia/Virology
A08.637
28
35.46
41
Brain Neoplasms/Virology
C04.588.614.250.195
27
35.88
42
AIDS-Related Opportunistic Infections/Drug Therapy
C01.539.597.050
27
36.30
43
Tumor Virus Infections/Microbiology
C02.928
27
36.72
44
Simian virus 40/Isolation and Purification
B04.280.640.615.700
27
37.14
45
Brain/Microbiology
A08.186.211
25
37.53
46
Kidney Transplantation
E02.870.500
25
37.91
47
Polyomavirus Infections/Diagnosis
C02.256.721
25
38.30
48
BK Virus/Immunology
B04.280.640.615.100
25
38.69
CP, cumulative percentage

Discussion

A systematic view of JCV papers to discern the distinct set of core researchers, institutional affiliations and corresponding countries helps us to gain a deeper understanding of approaches to JCV. As shown in our bibliometric analysis, the document type of JCV was original articles (1307/1785) and many data (209/1785) had been communicated in meeting activities. The review part occupies 6.9% (123/1785). The results indicated that JCV research was very active and interesting many investigators, and some scientists had begun to summary the achievement of JCV. Among 33 core authors, 19 persons come from Temple University, University of Tokyo, and National Institute of Neurological Disorder and Stroke, which ranked the top in the highly-produced institutes. Additionally, 14 (66.7%) core institutes of USA also focused on the investigation of JCV and USA was the first top producer of JCV papers until now. JVC was discovered in 1971 by American Padgett and named after the two initials of a patient with progressive multifocal leukoencephalopathy (PML). It was suggested that the JCV investigation originated from USA, which consequently became the top source information for JCV. It is rational and helpful for the scientists to tack the core authors and institutes to grasp the frontier of this field, open new projects and submit their distinguished work.
The list of top-cited articles about JCV identified the authors, articles and topics that reflected history and development of this specialty. Among highly-cited authors, Padgett is the discoverer for JCV in PML and published the first article in Lancet. The paper has been cited for 366 times and ranks the top in the highly-cited ones. His outstanding was also due to another article in Journal of Infectious disease, which described the detection of the antibody against JCV in PML. Therefore, it is explanatory for Padgett BL to be the most highly cited. These top-cited articles produced valuable information for readers, but also tell us some historical achievement in some field. According to these highly-cited papers, the research about JCV was chronologically separated into beginning and developing stages including discovery and isolation of JCV in PML disease, and clarification of JCV genomic DNA sequence and its relationship with diseases by polymerase chain reaction (PCR) respectively.
Most of highly-cited journals almost come from Virology, Neurology, and comprehensive journals, indicating JCV paper mainly absorbs frontier knowledge from these fields. Oncogene, Journal of Biological Chemistry, and International Journal of Cancer also become the highly-cited journal (data not shown), indicating the attempts of JCV study to combine with Molecular Biology and Oncology. This data also demonstrate the close link of JCV with these specialties. In the overall references of JCV papers, most highly-cited articles were published in Proceeding of National Academy and Science, USA and New England Journal of Medicine, indicating that these famous-brand journals highlight the investigation of JCV and emphasized the scientific achievement of JCV. Therefore, investigators of JCV not only read the journals of Virology, but also emphasized the novel findings of JCV published in other journals with high impact factor.
Methodologically, the cluster techniques include text segmentation, summary extraction, feature selection, term association, cluster generation, topic identification, and information mapping [19]. Clustering algorithms prominently used in co-citation analysis has proved very useful in revealing research streams in some discipline [2023]. Here, we carried out empirical co-citation analysis to map the network of highly-cited papers about JCV. Our data indicated that these top highly-cited articles were grouped into such 4 aspects as the correlation between JC virus and tumors, causal correlation of JCV with PML, polyoma virus infection and its related diseases in renal-allograft recipients, detection of JCV antibody, oncogene and its encoding protein, and genetics and molecular biology of JCV. These findings might not only enrich the knowledge of students and specialists about the development's history of JCV research, but also open new bursts of scientific investigation.
Co-occurrence has been considered as carriers of meaning across different domains in studies of science. Based on this principle, we performed co-occurrence cluster analysis using Pubmed MeSH/subheading words to construct a new tie between two words depending on the co-existing frequencies [24]. Consequently, most of the top highly-frequent MeSH/subheading words are mainly classified into C02 subcategory of MeSH (Viral Disease) and B04 subcategory (Viruses). The analytic data showed that the contents of published papers about JCV included JCV isolation and detection, as well as JCV and virus infectious diseases like PML or tumors. It was suggested that JCV investigation centered on its isolation, its pathogenicity of PML and its genetics at early time. Recently, the causal relationship between JCV and tumors has been emphasized by the scientists. It was demonstrated that JCV investigation like isolation and detection mainly aimed to clarify the molecular mechanism of its relevant diseases including PML and tumors.
As well known, JCV infection experiences two outcomes as other viruses. In un-permissive condition, JCV infection initiates binding to the JCV-sensitive cell surface and JCV capsids undergo endocytosis and are transported to the nucleus where the viral DNA is uncoated and the early and late region begins to be transcripted. Subsequently, JCV genomic DNA is assembled with caspid protein to undergo the lytic viral release, finally to cause demyelinating disease, PML. Under permissive infection, viral DNA can replicate, resulting in lytic infection with viral amplification and non-permissive cells don't allow the viral replication, leading to an abortive infection or cell transformation [69]. The evidence provided enough reasons for the following data: (1) The core and highly-cited journals mainly contained the field of virology, neurology and oncology; (2) The highly-cited articles and highly-frequent MeSH/subheading also mentioned the research contents of JCV, PML and tumors.
Recently, the further clarification of JCV genetics promoted the scientists to detect its genomic existence in tumors or make the transgenic mice to study the oncogenic role of JCV. Our group had examined the JCV targeting T antigen using nested-PCR, real-time PCR, in situ PCR, in situ hybridization, and immunohistochemistry [69]. It was found that positive rate and copies of JCV were higher in gastric, lung and tongue carcinomas than corresponding normal tissues, indicating its oncogenic role in epithelial carcinogenesis. Furthermore, JCV T antigen can serve as helicase, and polymerase, orchestrate the assembly and function of cellular proteins, disrupt the signal pathways of p53, Rb and Wnt signaling pathway, and should be considered as a viral oncogene [24]. Therefore, we are establishing a transgenic model of gastric neoplasia induced by JCV T antigen, which will help to verify the oncogenic role of JCV in gastric carcinoma and provide a novel tool to investigate gastric carcinomas. It was hypothesized that application of JCV T antigen in tumor transgenic animal model would be a novel and hot project in the future.

Conclusion

In this study, we successfully performed the scientometric analysis of JCV literature. Our data indicated that JCV mainly centered on PML and tumors. The bibliometric study assists researchers to know the history and frontier of JCV investigation, guide them to open new projects and submit the distinguished work. These cluster methods employed in this investigation can clarify the history, status and development in the field of JCV.

Acknowledgements

This study was supported by Natural Scientific Foundation of China (No.70473101; No. 30600286), Shenyang Outstanding Talent Foundation of China, Liaoning BaiQianWan Talents Program, Grant-in aid for Scientific Research from the Ministry of Education, Culture, Sports and Technology of Japan (20659109) and Smoking Research Foundation.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

HCZ conceived the study and wrote the first and final draft of the manuscript, analyzed interpretation. LY extracted the data and performed the analyses. LC kindly provided the bibliometric software and kindly guidance. YFG and YT gave many good suggestions about data processing and manuscript. All authors read and approved the final manuscript.
Anhänge

Authors’ original submitted files for images

Literatur
2.
Zurück zum Zitat Reiss K, Khalili K: Viruses and cancer lessons from the human polyomavirus, JCV. Oncogene. 2003, 22: 6517-6523. 10.1038/sj.onc.1206959.CrossRefPubMed Reiss K, Khalili K: Viruses and cancer lessons from the human polyomavirus, JCV. Oncogene. 2003, 22: 6517-6523. 10.1038/sj.onc.1206959.CrossRefPubMed
3.
Zurück zum Zitat White M, Khalili K: Expression of JC virus regulatory proteins in human cancer: potential mechanisms for tumourigenesis. Eur J Cancer. 2005, 41: 2537-2548. 10.1016/j.ejca.2005.08.019.CrossRefPubMed White M, Khalili K: Expression of JC virus regulatory proteins in human cancer: potential mechanisms for tumourigenesis. Eur J Cancer. 2005, 41: 2537-2548. 10.1016/j.ejca.2005.08.019.CrossRefPubMed
4.
Zurück zum Zitat Neel JV: Sanders Award Address for 1998: JC virus and its possible role in oncogenesis. Am J Med Genet. 1999, 83: 152-156. 10.1002/(SICI)1096-8628(19990319)83:3<152::AID-AJMG3>3.0.CO;2-O.CrossRefPubMed Neel JV: Sanders Award Address for 1998: JC virus and its possible role in oncogenesis. Am J Med Genet. 1999, 83: 152-156. 10.1002/(SICI)1096-8628(19990319)83:3<152::AID-AJMG3>3.0.CO;2-O.CrossRefPubMed
5.
Zurück zum Zitat Khalili K, Del Valle L, Otte J, Weaver M, Gordon J: Human neurotropic polyomavirus, JCV, and its role in carcinogenesis. Oncogene. 2003, 22: 5181-5191. 10.1038/sj.onc.1206559.CrossRefPubMed Khalili K, Del Valle L, Otte J, Weaver M, Gordon J: Human neurotropic polyomavirus, JCV, and its role in carcinogenesis. Oncogene. 2003, 22: 5181-5191. 10.1038/sj.onc.1206559.CrossRefPubMed
6.
Zurück zum Zitat Zheng H, Abdel Aziz HO, Nakanishi Y, Masuda S, Saito H, Tsuneyama K, Takano Y: Oncogenic role of JC virus in lung cancer. J Pathol. 2007, 212: 306-315. 10.1002/path.2188.CrossRefPubMed Zheng H, Abdel Aziz HO, Nakanishi Y, Masuda S, Saito H, Tsuneyama K, Takano Y: Oncogenic role of JC virus in lung cancer. J Pathol. 2007, 212: 306-315. 10.1002/path.2188.CrossRefPubMed
7.
Zurück zum Zitat Murai Y, Zheng HC, Abdel Aziz HO, Mei H, Kutsuna T, Nakanishi Y, Tsuneyama K, Takano Y: High JC virus load in gastric cancer and adjacent non-cancerous mucosa. Cancer Sci. 2007, 98: 25-31. 10.1111/j.1349-7006.2006.00354.x.CrossRefPubMed Murai Y, Zheng HC, Abdel Aziz HO, Mei H, Kutsuna T, Nakanishi Y, Tsuneyama K, Takano Y: High JC virus load in gastric cancer and adjacent non-cancerous mucosa. Cancer Sci. 2007, 98: 25-31. 10.1111/j.1349-7006.2006.00354.x.CrossRefPubMed
8.
Zurück zum Zitat Zheng H, Murai Y, Hong M, Nakanishi Y, Nomoto K, Masuda S, Tsuneyama K, Takano Y: JC virus detection in human tissue specimens. J Clin Pathol. 2007, 60: 787-793. 10.1136/jcp.2006.040915.CrossRefPubMedPubMedCentral Zheng H, Murai Y, Hong M, Nakanishi Y, Nomoto K, Masuda S, Tsuneyama K, Takano Y: JC virus detection in human tissue specimens. J Clin Pathol. 2007, 60: 787-793. 10.1136/jcp.2006.040915.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Kutsuna T, Zheng H, Abdel-Aziz HO, Murai Y, Tsuneyama K, Furuta I, Takano Y: High JC virus load in tongue carcinomas may be a risk factor for tongue tumorigenesis. Virchows Arch. 2008, 452: 405-410. 10.1007/s00428-007-0534-0.CrossRefPubMedPubMedCentral Kutsuna T, Zheng H, Abdel-Aziz HO, Murai Y, Tsuneyama K, Furuta I, Takano Y: High JC virus load in tongue carcinomas may be a risk factor for tongue tumorigenesis. Virchows Arch. 2008, 452: 405-410. 10.1007/s00428-007-0534-0.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Estabrooks CA, Winther C, Derksen L: Mapping the field: a bibliometric analysis of the research utilization literature in nursing. Nurs Res. 2004, 53: 293-303. 10.1097/00006199-200409000-00003.CrossRefPubMed Estabrooks CA, Winther C, Derksen L: Mapping the field: a bibliometric analysis of the research utilization literature in nursing. Nurs Res. 2004, 53: 293-303. 10.1097/00006199-200409000-00003.CrossRefPubMed
11.
Zurück zum Zitat Oelrich B, Peters R, Jung K: A bibliometric evaluation of publications in urological journals among European union countries between 2000–2005. Eur Urol. 2007, 52: 1238-1248. 10.1016/j.eururo.2007.06.050.CrossRefPubMed Oelrich B, Peters R, Jung K: A bibliometric evaluation of publications in urological journals among European union countries between 2000–2005. Eur Urol. 2007, 52: 1238-1248. 10.1016/j.eururo.2007.06.050.CrossRefPubMed
12.
Zurück zum Zitat Golder S, McIntosh HM, Duffy S, Glanville J: Centre for Reviews and Dissemination and UK Cochrane Centre Search Filters Design Group: Developing efficient search strategies to identify reports of adverse effects in MEDLINE and EMBASE. Health Info Libr J. 2006, 23: 3-12. 10.1111/j.1471-1842.2006.00634.x.CrossRefPubMed Golder S, McIntosh HM, Duffy S, Glanville J: Centre for Reviews and Dissemination and UK Cochrane Centre Search Filters Design Group: Developing efficient search strategies to identify reports of adverse effects in MEDLINE and EMBASE. Health Info Libr J. 2006, 23: 3-12. 10.1111/j.1471-1842.2006.00634.x.CrossRefPubMed
13.
Zurück zum Zitat Darmoni SJ, Névéol A, Renard JM, Gehanno JF, Soualmia LF, Dahamna B, Thirion B: A MEDLINE categorization algorithm. BMC Med Inform Decis Mak. 2006, 6: 7-10.1186/1472-6947-6-7.CrossRefPubMedPubMedCentral Darmoni SJ, Névéol A, Renard JM, Gehanno JF, Soualmia LF, Dahamna B, Thirion B: A MEDLINE categorization algorithm. BMC Med Inform Decis Mak. 2006, 6: 7-10.1186/1472-6947-6-7.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Chang AA, Heskett KM, Davidson TM: Searching the literature using medical subject headings versus text word with PubMed. Laryngoscope. 2006, 116: 336-340. 10.1097/01.mlg.0000195371.72887.a2.CrossRefPubMed Chang AA, Heskett KM, Davidson TM: Searching the literature using medical subject headings versus text word with PubMed. Laryngoscope. 2006, 116: 336-340. 10.1097/01.mlg.0000195371.72887.a2.CrossRefPubMed
15.
Zurück zum Zitat Zheng HC, Yu XO, Xin Y: Antigen CD44 with clustered analysis of co-terms: a status quo investigation. Chin J Med Libr Info Sci. 2002, 11 (2): 1-3. Zheng HC, Yu XO, Xin Y: Antigen CD44 with clustered analysis of co-terms: a status quo investigation. Chin J Med Libr Info Sci. 2002, 11 (2): 1-3.
16.
Zurück zum Zitat Zheng HC, Cui L: Co-term and co-occurrence clustered analysis of lowly-cited articles on gastric precancerous lesions. Chin J Med Libr Info Sci. 2002, 11 (3): 1-3. Zheng HC, Cui L: Co-term and co-occurrence clustered analysis of lowly-cited articles on gastric precancerous lesions. Chin J Med Libr Info Sci. 2002, 11 (3): 1-3.
17.
Zurück zum Zitat Zheng HC: Exploring the history and status of gastric precancerous lesions with chronological and clusteranalysis of cited articles. Acta Acad Med CPAPF. 2002, 10: 249-251. Zheng HC: Exploring the history and status of gastric precancerous lesions with chronological and clusteranalysis of cited articles. Acta Acad Med CPAPF. 2002, 10: 249-251.
18.
Zurück zum Zitat Ochiai A: Zoographic studies on the solenoid fishes found in Japan and its neighbouring regions. Bull Japan Soc Sci Fish. 1957, 22: 526-530.CrossRef Ochiai A: Zoographic studies on the solenoid fishes found in Japan and its neighbouring regions. Bull Japan Soc Sci Fish. 1957, 22: 526-530.CrossRef
19.
Zurück zum Zitat Tseng YH, Lin CJ, Lin YI: Text mining techniques for patent analysis. Inform Process Manag. 2007, 43: 1216-1247. 10.1016/j.ipm.2006.11.011.CrossRef Tseng YH, Lin CJ, Lin YI: Text mining techniques for patent analysis. Inform Process Manag. 2007, 43: 1216-1247. 10.1016/j.ipm.2006.11.011.CrossRef
20.
Zurück zum Zitat Prime C, Bassecoulard E, Zitt M: Co-citations and co-sitations: A cautionary view on an analogy. Scientometrics. 2002, 54: 291-308. 10.1023/A:1016022214005.CrossRef Prime C, Bassecoulard E, Zitt M: Co-citations and co-sitations: A cautionary view on an analogy. Scientometrics. 2002, 54: 291-308. 10.1023/A:1016022214005.CrossRef
21.
Zurück zum Zitat Zubiete CL: An application of co-citation based visualisation techniques in the field of film studies. Prof De La Inform. 2006, 15: 251-257. 10.3145/epi.2006.jul.02. Zubiete CL: An application of co-citation based visualisation techniques in the field of film studies. Prof De La Inform. 2006, 15: 251-257. 10.3145/epi.2006.jul.02.
22.
Zurück zum Zitat Schildt HA, Mattsson JT: A dense network sub-grouping algorithm for co-citation analysis and its implementation in the software tool Sitkis. Scientometrics. 2006, 67: 143-163. 10.1007/s11192-006-0054-8.CrossRef Schildt HA, Mattsson JT: A dense network sub-grouping algorithm for co-citation analysis and its implementation in the software tool Sitkis. Scientometrics. 2006, 67: 143-163. 10.1007/s11192-006-0054-8.CrossRef
23.
Zurück zum Zitat Reid EF, Chen HC: Mapping the contemporary terrorism research domain. Int J Hum-Comput St. 2007, 65: 42-56. 10.1016/j.ijhcs.2006.08.006.CrossRef Reid EF, Chen HC: Mapping the contemporary terrorism research domain. Int J Hum-Comput St. 2007, 65: 42-56. 10.1016/j.ijhcs.2006.08.006.CrossRef
24.
Zurück zum Zitat Marx W, Schier H, Wanitschek M: Citation analysis using online databases: feasibilities and shorcomings. Scientometrics. 2001, 52: 59-82. 10.1023/A:1012798911792.CrossRef Marx W, Schier H, Wanitschek M: Citation analysis using online databases: feasibilities and shorcomings. Scientometrics. 2001, 52: 59-82. 10.1023/A:1012798911792.CrossRef
Metadaten
Titel
Mapping the history and current situation of research on John Cunningham virus – a bibliometric analysis
verfasst von
Hua-chuan Zheng
Lei Yan
Lei Cui
Yi-fu Guan
Yasuo Takano
Publikationsdatum
01.12.2009
Verlag
BioMed Central
Erschienen in
BMC Infectious Diseases / Ausgabe 1/2009
Elektronische ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-9-28

Weitere Artikel der Ausgabe 1/2009

BMC Infectious Diseases 1/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.